Latest News

Seroba Kernel Co-leads £5m Investment in Veryan Medical.

Dublin, Ireland, November 1, 2011. Seroba Kernel Life Sciences (Seroba Kernel) and Imperial Innovations Group (Innovations) have co-led a £5m funding round into Veryan Medical, which is developing innovative solutions for vascular disease using its unique Biomimics 3D™ stent technology.

Sir Gregory Winter joins Covagen’s Scientific Advisory Board.

Switzerland, September 20, 2011. Covagen announced today that Sir Gregory Winter is joining its Scientific Advisory Board.  Sir Gregory Winter is a member of the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge, and a Fellow of Trinity College Cambridge (UK).&

Alimentary Health enters partnership with Norgine.

26th August 2011.  Alimentary Health Limited (AH), the specialty biotechnology company, today announces that it has entered into a development partnership with Norgine, a leading European specialty pharmaceutical company with a strong portfolio of internal development projects, principally in t